The long-term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis-52 week results from the Dutch BioDay Registry.
Journal Information
Full Title: Contact Dermatitis
Abbreviation: Contact Dermatitis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"CONFLICTS OF INTEREST Dr M.L.A.S. is an advisor, consultant, speaker, and/or investigator for AbbVie, Pfizer, LEO Pharma, Regeneron, Sanofi Genzyme, Eli Lilly, and Galderma. She has received grants from Regeneron, Sanofi Genzyme, Novartis, and Pfizer. M.S.B‐W. is a principal investigator, consultant, and advisory board member for AbbVie, Regeneron Pharmaceuticals, Inc, Sanofi Genzyme, Leo Pharma, and Pfizer; and is an advisory board member and consultant for Arena, ASLAN, Galderma, and Eli Lilly. A.N.V. and G.L.E.R. have no conflicts of interest to declare."
"Funding information Supported by Sanofi and Regeneron Pharmaceuticals."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025